Zelluna ASA [ZLNA]: Annual Report 2025

Core Insights - Zelluna ASA is focused on pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies aimed at treating solid cancers [1] - The Board of Directors of Zelluna ASA has approved the Annual Report for the year 2025 [1] - The Annual Report is available in PDF format and in European Single Electronic Format (ESEF), and can also be accessed on the company's website [1] Company Information - Zelluna ASA's Chairman of the Board is Anders Tuv, and the CEO is Namir Hassan [2] - The CFO of Zelluna ASA is Geir Christian Melen [2] - Contact information for the company's leadership is provided for further inquiries [2]